title: Real-world evidence with apixaban for stroke prevention in patients with nonvalvular atrial fibrillation in Germany: a retrospective study (REASSESS).
authors.affiliation: School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, CT, 06269, USA. craig.coleman@hhchealth.org.
authors.forename: Craig Ian
authors.initials: CI
authors.lastname: Coleman
authors.affiliation: Department of Cardiology, Hospital Oldenburg, Oldenburg, Germany.
authors.forename: Matthias
authors.initials: M
authors.lastname: Antz
mesh_terms: D000368:Aged; D001281:Atrial Fibrillation / Q000188:drug therapy*; D065427:Factor Xa Inhibitors / Q000627:therapeutic use*; D005260:Female; D005858:Germany; D006801:Humans; D008297:Male; D008875:Middle Aged; D057216:Propensity Score; D011720:Pyrazoles / Q000627:therapeutic use*; D011728:Pyridones / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control*
chemical_list: D065427:Factor Xa Inhibitors; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban